GLP-1 agonist - Health Rising

Stepping Backwards – the U.S.’s Attempt to Politicize Scientific Research: An Editorial

ME/CFS Autopsy Study Finds a Wrecked HPA Axis: The 2025 IACFS/ME Conference Report #3

by Cort Johnson | Dec 4, 2025 | Baricitinib, Bezisterim, Brain, Cortene, Drugs, GLP-1, GLP-1 agonist, Homepage, HPA axis, Locus coeruleus, Low Dose Naltrexone, Neuroinflammation, Neuroinflammation, Neuroplasticity, Norepinephrine, Research, Suramin, Treatment

A Dutch ME/CFS autopsy report findings multiple severe problems in the HPA axis of ME/CFS patients.

Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program

by Cort Johnson | Nov 16, 2025 | Autonomic Nervous System, Brain, Brainstem, Clonidine, CoQ10, D-Ribose, GLP-1, GLP-1 agonist, Guanfacine, Homepage, Ivabradine, Kaiser, L-carntine/Acetylcarnitine, Locus coeruleus, Mast cell activation syndrome, Mestinon, Neuroplasticity, Neuroplasticity, Norepinephrine, Pacing, Prefrontal Cortex, Propanolol, Rapamycin, Research, Stimulants, Urolithin A

Check out how ChatGPT thinks people with ME/CFS and long COVID might treat the low norepinephine brain findings in these diseases.

RECOVER’s 2nd Round of Long COVID Clinical Trials Shows Progress… and Limitations

by Cort Johnson | Oct 10, 2025 | Baricitinib, GLP-1, GLP-1 agonist, Homepage, Low Dose Naltrexone, NIH, Stellate Ganglion Block, Treatment

The RECOVER Initiative announces four more clinical trials for long COVID including low dose naltrexone, bariticinib, GLP-1 agonists, and stellate ganglion blockade.

Subscribe To Health Rising’s Free Chronic Fatigue Syndrome, Fibromyalgia and Long COVID Information

Support Health Rising

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Lives Interrupted

Lives Interrupted Latest Story

Homebound

ABC

Mount Vernon, United States

Total Economic Losses:

$257,601

Lives Interrupted Stats

Number of Stories: 48

Years of Work Lost: 349

Average Total Economic Losses:

$830,173

Total Economic Losses:

$29,056,046

StudyME

Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.

Find out more here

Enroll here

A BIG thanks to everyone whose contributions helped make Health Rising's summer drive a success :)

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.

Stepping Backwards – the U.S.’s Attempt to Politicize Scientific Research: An Editorial

ME/CFS Autopsy Study Finds a Wrecked HPA Axis: The 2025 IACFS/ME Conference Report #3

Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program

RECOVER’s 2nd Round of Long COVID Clinical Trials Shows Progress… and Limitations

Subscribe

Support Health Rising

Lives Interrupted

Lives Interrupted Latest Story

Lives Interrupted Stats

StudyME

Simmaron Research

ME/CFS & Fibromyalgia Treatment Room

May 12th - International ME/CFS & FM Awareness Day

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Thank you for signing up!

Pin It on Pinterest